Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Nithrakashyap ArvindDirector, Chief Technology Officer | Derivative conversion · 10b5-1 plan | C | — 12.8K sh |
| Sep 10, 2026 traded Sep 10, 2026 |
| 0 | Benevich EricChief Commercial Officer | Option exercise · 10b5-1 plan | M | — 3,194 sh | Sep 10, 2026 traded Sep 9, 2026 |
| 0 | Nithrakashyap ArvindDirector, Chief Technology Officer | Derivative conversion · 10b5-1 plan | C | — 12.8K sh | Sep 10, 2026 traded Sep 10, 2026 |
| 0 | Nithrakashyap ArvindDirector, Chief Technology Officer | Derivative conversion · 10b5-1 plan | C | — 12.8K sh | Sep 10, 2026 traded Sep 9, 2026 |
| 0 | Kleinerman ChristianEVP, Product Management | Tax withholding · 10b5-1 plan | F | $305K 904 sh | Sep 10, 2026 traded Sep 8, 2026 |
| 0 | Nithrakashyap ArvindDirector, Chief Technology Officer | Derivative conversion · 10b5-1 plan | C | — 12.8K sh | Sep 10, 2026 traded Sep 9, 2026 |
| 0 | King Ryan ADirector, Co-Founder | Derivative conversion · 10b5-1 plan | C | — 34.9K sh | Sep 10, 2026 traded Sep 9, 2026 |
| 0 | Nithrakashyap ArvindDirector, Chief Technology Officer | Derivative conversion · 10b5-1 plan | C | — 12.8K sh | Sep 10, 2026 traded Sep 8, 2026 |
| 0 | Intrator Michael NDirector, CEO and President, 10% Owner | Option exercise · 10b5-1 plan | M | — 107.7K sh | Sep 10, 2026 traded Sep 8, 2026 |
| 0 | Kleinerman ChristianEVP, Product Management | Tax withholding · 10b5-1 plan | F | $626K 1,858 sh | Sep 10, 2026 traded Sep 8, 2026 |
| 0 | Evans Katie SeitzSee Remarks | Option exercise · 10b5-1 plan | M | — 13.5K sh | Sep 10, 2026 traded Sep 8, 2026 |
| 0 | Dageville BenoitDirector | Tax withholding · 10b5-1 plan | F | $187K 555 sh | Sep 10, 2026 traded Sep 8, 2026 |
| 0 | McVeety Kristen JGC and Secretary | Option exercise · 10b5-1 plan | M | — 97.5K sh | Sep 10, 2026 traded Sep 8, 2026 |
| 58 | Saavedra Jennifer D.Chief Human Resources Officer | Open-market sale | SELL | $13.13M 25.3K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 51 | Tiran AssafEVP Cross Suez & Atlantic BU | Open-market sale | SELL | $70K 2,312 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 51 | Tunnell JaneChief Marketing Officer | Open-market sale | SELL | $2.85M 5,436 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 50 | Grube JamesDirector | Open-market purchase | BUY | $196K 10.3K sh | Sep 9, 2026 traded Sep 9, 2026 |
| 48 | Elimelech ArikEVP HR & Organization | Open-market sale | SELL | $14K 458 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 43 | Cashman SteveChief Business Officer | Open-market sale | SELL | $1.02M 140.1K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 43 | Muller Frank L.Director | Open-market purchase | BUY | $9,959 450 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 41 | Landesberg StuartDirector | Open-market purchase | BUY | $248 241 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 40 | Peyovich Daniel SPresident & CEO | Open-market purchase | BUY | $252K 850 sh | Sep 9, 2026 traded Sep 9, 2026 |
| 39 | Aquilino BrianChief Operating Officer | Open-market sale | SELL | $313K 6,667 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 38 | Budur KumarCHIEF MEDICAL OFFICER | Open-market sale | SELL | $231K 5,500 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 38 | Mulshine Brendan MartinCo-President and CRO | Open-market sale | SELL | $1.62M 40.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 37 | Larson Keith DGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $28.69M 1.89M sh | Sep 9, 2026 traded Sep 9, 2026 |
| 36 | Collier CharlesPresident, Roku Media | Open-market sale · 10b5-1 plan | SELL | $1.39M 8,843 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 36 | Collier CharlesPresident, Roku Media | Open-market sale · 10b5-1 plan | SELL | $1.39M 8,843 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 36 | Carlson MeganCAO and SVP, Finance | Open-market sale | SELL | $101K 13.8K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 35 | Dotan SaarEVP Countries & BD | Open-market sale | SELL | $88K 2,890 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 35 | Lin Elizabeth YeuChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $485K 5,386 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 35 | Budur KumarCHIEF MEDICAL OFFICER | Open-market sale | SELL | $989K 23.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 34 | Larson Keith DGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $6.98M 464.2K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 34 | Sluis FrankCFO | Open-market sale | SELL | $19K 687 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 32 | Clerc AlexandreSVP, Customers | Open-market sale | SELL | $20K 3,480 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 32 | Dotan SaarEVP Countries & BD | Open-market sale | SELL | $24K 800 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 32 | Lindgardt ZhenyaDirector, Chief Executive Officer | Open-market sale | SELL | $40K 20.1K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 32 | Lin Elizabeth YeuChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $143K 1,590 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 32 | Chin Peter ScottChief Medical Officer | Open-market sale | SELL | $37K 1,654 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 31 | Lin Elizabeth YeuChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $458K 5,387 sh | Sep 9, 2026 traded Sep 4, 2026 |